Analyst Upgrades: Ambarella Inc, Broadcom Ltd, and Ciena Corporation

Analysts upwardly revised their ratings and price targets on Ambarella Inc (NASDAQ:AMBA), Broadcom Ltd (NASDAQ:AVGO), and Ciena Corporation (NYSE:CIEN)

by Josh Selway

Published on Sep 2, 2016 at 9:17 AM

Analysts are weighing in on tech stocks Ambarella Inc (NASDAQ:AMBA), Broadcom Ltd (NASDAQ:AVGO), and Ciena Corporation (NYSE:CIEN). Here's a quick roundup of today's bullish brokerage notes on AMBA, AVGO, and CIEN.

  • AMBA has lost 1.8% in electronic trading, even though the company topped Wall Street's earnings and sales forecasts, and offered a solid current-quarter revenue outlook. What's more, Deutsche Bank, Morgan Stanley, and Canaccord Genuity all raised their price targets, with the latter setting the highest mark of $86 -- territory not explored in over a year. At $71.78, Ambarella Inc is up almost 29% in 2016, and although short interest has been declining sharply for months, roughly 22% of the stock's float remains sold short

  • Fellow chipmaker AVGO is also moving lower in pre-market action, despite seemingly strong quarterly results. Specifically, the company topped analysts' expectations for earnings and revenue, and provided an upbeat sales outlook, but the stock is still down 0.6% ahead of the open. A post-earnings plunge wouldn't be totally unexpected, as options traders have been bracing for such a move. Meanwhile, a number of brokerage firms raised their price targets on Broadcom Ltd, including a hike to $220 at J.P Morgan Securities -- representing all-time-high territory. Speaking of all-time highs, AVGO hit one earlier this week at $179.42, and settled just below it yesterday at $177.09.  

  • After soaring yesterday on an earnings beat of its ownCIEN is getting sized up by analysts. B. Riley was one of at least six brokerage firms to raise its price target on the stock, putting it at $28.50 -- and in five-year-high territory -- though Morgan Stanley weighed in with a downgrade to "equal weight" from "overweight." Coming into today, analysts were already extremely bullish on CIEN, with 12 of 13 rating it a "buy" or better, and zero calling it a "sell." Still, Ciena Corporation has edged 2% lower ahead of the open, as the shares struggle to close their huge bear gap from December. Plus, CIEN's 14-day Relative Strength Index (RSI) checks in at 72, in overbought territory. The stock settled yesterday at $23.17, its highest close of 2016.
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.